SER earnings: a negative outcome, -11.0%

On November 10, 2022, Serina Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.0% in the window around the event. It had already run +14.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.